Demographic, Clinical, and Surgical Risk Factors of Pars Plana Vitrectomy (PPV) for Neovascular Glaucoma (NVG) Development in Type 2 Diabetes Mellitus Patients.
GLP-1 Receptor Agonists and Sight-Threatening Ophthalmic Complications in Patients With Type 2 Diabetes.
Ramsey DJ, Makwana B, Dani SS, Patel M, Panchal K, Shah J, Khadke S, Kumar A, Patel T, Kosiborod MN, Fonarow GC, Ramsey KM, Nohria A, Butler J, Ganatra S.
JAMA Netw Open. 2025 Aug 1;8(8):e2526321. doi: 10.1001/jamanetworkopen.2025.26321.
Diabetes-related eye disorders.
Sanders RJ, Wilson MR.
J Natl Med Assoc. 1993 Feb;85(2):104-8.
Demographic, Clinical, and Surgical Risk Factors of Pars Plana Vitrectomy (PPV) for Neovascular Glaucoma (NVG) Development in Type 2 Diabetes Mellitus Patients.
Nisic F, Lepara O, Jahić R, Begić E, Alic L, Fajkić A.
Cureus. 2024 Sep 17;16(9):e69571. doi: 10.7759/cureus.69571. eCollection 2024 Sep.
Systemic and ocular outcomes in patients with young-onset type 2 diabetes.
Au A, Bajar BT, Wong BM, Daskivich LP, Hosseini H, Prasad PS.
J Diabetes Complications. 2024 Feb;38(2):108670. doi: 10.1016/j.jdiacomp.2023.108670. Epub 2023 Dec 22.
A neural network model for predicting the effectiveness of treatment in patients with neovascular glaucoma associated with diabetes mellitus.
Guzun OV, Zadorozhnyy OS, Vychuzhanin VV, Khramenko NI, Velichko LM, Korol AR, Cușnir VN, Dumbrăveanu LG, Cușnir VV.
Rom J Ophthalmol. 2024 Jul-Sep;68(3):294-300. doi: 10.22336/rjo.2024.53.
Demographic, Socioeconomic, and Clinical Factors Associated with Severe Vision Loss in Patients with Neovascular Glaucoma.
Cotton CC, Goerl BA, Kaplan EF, Krause MA.
Clin Ophthalmol. 2024 Jul 19;18:2137-2145. doi: 10.2147/OPTH.S452884. eCollection 2024.
Incidence of Proliferative Diabetic Retinopathy and Other Neovascular Sequelae at 5 Years Following Diagnosis of Type 2 Diabetes.
Gange WS, Lopez J, Xu BY, Lung K, Seabury SA, Toy BC.
Diabetes Care. 2021 Nov;44(11):2518-2526. doi: 10.2337/dc21-0228. Epub 2021 Sep 2.
Clinical Characteristics and Surgical Outcomes of Complications of Proliferative Diabetic Retinopathy in Young versus Older Patients with Type 2 Diabetes.
Zhang M, Xu G, Ruan L, Huang X, Zhang T.
Diabetes Metab Syndr Obes. 2023 Jan 11;16:37-45. doi: 10.2147/DMSO.S382603. eCollection 2023.
Effect of orbital manifestations among type 2 diabetes mellitus patients.
Achwal GM, V H K, B S J.
Bioinformation. 2025 Mar 31;21(3):529-533. doi: 10.6026/973206300210529. eCollection 2025.
Functional and structural outcomes and complications after pars plana vitrectomy for severe features of proliferative diabetic retinopathy in type 1 and type 2 diabetes mellitus.
Kaźmierczak K, Żuchowski P, Stafiej J, Malukiewicz G.
PLoS One. 2023 Jul 20;18(7):e0288805. doi: 10.1371/journal.pone.0288805. eCollection 2023.
